← Back to Patent Explorer
US3715188A Expired / Lapsed US ⏱️ 0.0 years remaining

Cholesterol assay and reagents therefor

Assignee: INDIANA DEVELOPMENT FINANCE AUTHORITY
•
Filing: 1971-04-30
•
Granted: 1973-02-06
•
Expires: 1991-04-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A cholesterol assay, using formamide, which achieves the simplicity of a direct test of a specimen sample, yet which also achieves a comparable specificity and accuracy of cholesterol assays involving multiple-extraction steps. The formamide destroys the cholesterol chromophore of a blank measurement, and this result may be compared with a companion cholesterol assay to eliminate the error caused by the chromophore of non-cholesterol chromogenic substances of the specimen; and the formamide also keeps the alcohol, which is used to prevent turbidity, from blocking the formation of the bilirubin portion of the noncholesterol chromogenic substances.

Inventors

  • 👤 J Denney

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 21:34
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/92; Y; Y10; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/255

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 46 words
A process for the quantitative colorimetric or spectrophotometric determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide to said material for preventing the formation of a chromophore from the cholesterol chromogen in the sample being assayed.
Claim 2
Dependent Claim 46 words
A process for the quantitative colorimetric or spectrophotometric determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide to said material for preventing the formation of a chromophore from the cholesterol chromogen in the sample being assayed.
Claim 3
Dependent Claim 72 words
The process as set forth in claim 1 in which the formamide is added to a first portion of said material to prevent the said formation of the cholesterol chromophore to provide a blank measurement, and in which formamide is omitted from a second portion of said material to provide a test measurement, and comparing the blank measurement with the test measurement, whereby a quantitative determination of the cholesterol itself is achieved.
Claim 4
Dependent Claim 59 words
A process for the quantitative determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide and a high molecular weight alcohol to said material for preventing the formation of chromophore from the cholesterol chromogen in the sample being assayed, while permitting the formation of the chromophore from the bilirubin chromogen.
Claim 5
Dependent Claim 59 words
A process for the quantitative determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide and a high molecular weight alcohol to said material for preventing the formation of chromophore from the cholesterol chromogen in the sample being assayed, while permitting the formation of the chromophore from the bilirubin chromogen.
Claim 6
Dependent Claim 19 words
The process as set forth in claim 3, the alcohol having from eight to sixteen carbon atoms per molecule.
Claim 7
Dependent Claim 15 words
The process as set forth in claim 3 in which the alcohol is tridecyl alcohol.
Claim 8
Dependent Claim 15 words
The process as ser forth in claim 3 in which the alcohol is hexadecyl alcohol.
Claim 9
Dependent Claim 21 words
The process as set forth in claim 3 in which the high molecular weight alcohol is added to the cholesterol reagent.
Claim 10
Dependent Claim 124 words
A process for the quantitative determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide to block the formation of the chromophore from the cholesterol chromogen in a first portion of the sample while causing the non-cholesterol chromogenic substances in the said first portion of the sample to produce their chromophores, and in a second portion of the sample the step of causing the formation of chromophore from the sample''s substance including both its said non-cholesterol chromogenic substances and its cholesterol chromogen, by omitting formamide, and comparing the chromophore of the two sample portions to quantitatively determine the cholesterol content of the sample by the contrast of the chromophore produced in the two sample portions.
Claim 11
Dependent Claim 124 words
A process for the quantitative determination of cholesterol in serum, plasma, or other biological material to be tested, wherein the improvement comprises adding formamide to block the formation of the chromophore from the cholesterol chromogen in a first portion of the sample while causing the non-cholesterol chromogenic substances in the said first portion of the sample to produce their chromophores, and in a second portion of the sample the step of causing the formation of chromophore from the sample''s substance including both its said non-cholesterol chromogenic substances and its cholesterol chromogen, by omitting formamide, and comparing the chromophore of the two sample portions to quantitatively determine the cholesterol content of the sample by the contrast of the chromophore produced in the two sample portions.
Claim 12
Dependent Claim 62 words
A process according to claim 8, in which a mixture of acetic acid, acetic anhydride, and sulfuric acid is added to the first and second portions to cause the non-cholesterol chromogenic substances in the said first portion of the sample to produce their chromophores and also to cause the formation of chromophore from the sample in the second portion of the reaction.
Claim 13
Dependent Claim 16 words
The process according to claim 9 in which the mixture includes a high molecular weight alcohol.

References Cited (Backward Citations)

US3558516A Cited
US3615232A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-02-06 1976-08-07 1977-02-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-02-06 1980-08-07 1981-02-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-02-06 1984-08-07 1985-02-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag